Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nail Benallegue

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Immunological Reviews|July 31, 2022
Neuroinflammation: Extinguishing a blaze of T cellsNail Benallegue, Hania Kebir, Jorge I Alvarez
Expert Review of Neurotherapeutics|May 30, 2025
Optimizing treatment for pediatric multiple sclerosisNail Benallegue, Fabien Rollot, David-Axel Laplaud
BMC Pediatrics|October 14, 2025
Acute severe hypernatremia complicated by osmotic demyelination syndrome in a 13-day-old infantMélanie Bonet, Nail Benallegue, Patrick Desbordes De Cepoy, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|September 5, 2021
Neurological involvement in secondary hemophagocytic lymphohistiocytosis in childrenNail Benallegue, Frédérique Beaudonnet, Béatrice Husson, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 24, 2024
School-entry age and academic difficulties at 7 years of age in children born very preterm: A call for age-corrected schooling: School-entry age and academic difficulties at 7 years of age in children born very pretermJean-Christophe Roze, Geraldine Apprioual, Andrei Scott Morgan, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 20, 2022
Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8<sup>+</sup> Regulatory T CellsNail Benallegue, Bryan Nicol, Juliette Lasselin, et al.
Brain : a Journal of Neurology|March 16, 2021
The hedgehog pathway suppresses neuropathogenesis in CD4 T cell-driven inflammationNail Benallegue, Hania Kebir, Richa Kapoor, et al.
JAMA Neurology|February 12, 2024
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple SclerosisNail Benallegue, Fabien Rollot, Sandrine Wiertlewski, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosisNail Benallegue, Fabien Rollot, Pietro Iaffaldano, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Immunological Reviews|July 31, 2022
Neuroinflammation: Extinguishing a blaze of T cellsNail Benallegue, Hania Kebir, Jorge I Alvarez
Expert Review of Neurotherapeutics|May 30, 2025
Optimizing treatment for pediatric multiple sclerosisNail Benallegue, Fabien Rollot, David-Axel Laplaud
BMC Pediatrics|October 14, 2025
Acute severe hypernatremia complicated by osmotic demyelination syndrome in a 13-day-old infantMélanie Bonet, Nail Benallegue, Patrick Desbordes De Cepoy, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|September 5, 2021
Neurological involvement in secondary hemophagocytic lymphohistiocytosis in childrenNail Benallegue, Frédérique Beaudonnet, Béatrice Husson, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 24, 2024
School-entry age and academic difficulties at 7 years of age in children born very preterm: A call for age-corrected schooling: School-entry age and academic difficulties at 7 years of age in children born very pretermJean-Christophe Roze, Geraldine Apprioual, Andrei Scott Morgan, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 20, 2022
Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8<sup>+</sup> Regulatory T CellsNail Benallegue, Bryan Nicol, Juliette Lasselin, et al.
Brain : a Journal of Neurology|March 16, 2021
The hedgehog pathway suppresses neuropathogenesis in CD4 T cell-driven inflammationNail Benallegue, Hania Kebir, Richa Kapoor, et al.
JAMA Neurology|February 12, 2024
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple SclerosisNail Benallegue, Fabien Rollot, Sandrine Wiertlewski, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosisNail Benallegue, Fabien Rollot, Pietro Iaffaldano, et al.
Pageof 1